KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Equity Income (2016 - 2025)

Evolent Health (EVH) has 11 years of Equity Income data on record, last reported at $31000.0 in Q4 2025.

  • For Q4 2025, Equity Income fell 84.5% year-over-year to $31000.0; the TTM value through Dec 2025 reached $365000.0, up 110.74%, while the annual FY2025 figure was $365000.0, 110.74% up from the prior year.
  • Equity Income reached $31000.0 in Q4 2025 per EVH's latest filing, down from $156000.0 in the prior quarter.
  • Across five years, Equity Income topped out at $7.8 million in Q1 2021 and bottomed at -$2.2 million in Q3 2024.
  • Average Equity Income over 5 years is $807150.0, with a median of $253000.0 recorded in 2024.
  • Peak YoY movement for Equity Income: soared 2109.52% in 2022, then plummeted 1196.77% in 2024.
  • A 5-year view of Equity Income shows it stood at $500000.0 in 2021, then skyrocketed by 32.0% to $660000.0 in 2022, then plummeted by 95.76% to $28000.0 in 2023, then surged by 614.29% to $200000.0 in 2024, then crashed by 84.5% to $31000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Income were $31000.0 in Q4 2025, $156000.0 in Q3 2025, and $197000.0 in Q2 2025.